United Capital Financial Advisors’s SOLAZYME INC COM STK (DE) SZYM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q1
Sell
-277,005
Closed -$687K 1315
2015
Q4
$687K Sell
277,005
-4,500
-2% -$13.3K 0.01% 793
2015
Q3
$732K Sell
281,505
-4,374
-2% -$11.4K 0.01% 779
2015
Q2
$898K Sell
285,879
-756,605
-73% -$2.59M 0.01% 747
2015
Q1
$4.01M Buy
1,042,484
+500,673
+92% +$1.28M 0.05% 382
2014
Q4
$1.4M Buy
541,811
+392,437
+263% +$1.72M 0.02% 560
2014
Q3
$1.11M Buy
+149,374
New +$1.4M 0.02% 582

Other funds holding SZYM

United Capital Financial Advisors's SZYM Position: Q1 2016 in Review

United Capital Financial Advisors sold out of SOLAZYME INC COM STK (DE) (SZYM) in Q1 2016, closing a stake of 277,005 shares — an estimated $687K sold.

United Capital Financial Advisors first reported a position in SZYM in Q3 2014 and held it in 6 quarters. The position peaked at $4.01M in Q1 2015. 99 funds tracked by Wall St. Rank hold SZYM as of Q1 2016.

  • United Capital Financial Advisors reported no remaining SOLAZYME INC COM STK (DE) position as of Q1 2016 after selling out during the quarter.
  • United Capital Financial Advisors sold 277,005 SOLAZYME INC COM STK (DE) shares in Q1 2016, an estimated $687K.
  • United Capital Financial Advisors first reported a position in SOLAZYME INC COM STK (DE) in Q3 2014 and held it in 6 quarters.
  • United Capital Financial Advisors's SOLAZYME INC COM STK (DE) position peaked at $4.01M in Q1 2015.
  • 99 funds tracked by Wall St. Rank held SOLAZYME INC COM STK (DE) as of Q1 2016.

Based on United Capital Financial Advisors's 13F filing for Q1 2016, filed 11 May 2016.